Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants
Crossref DOI link: https://doi.org/10.1136/openhrt-2018-000788
Published Online: 2018-04-21
Published Print: 2018-04
Update policy: https://doi.org/10.1136/crossmarkpolicy
Camm, A John
Fox, Keith A A
Funding for this research was provided by:
Bayer AG